Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0011570 (depression)
 172,036 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Seventy three patients (63 males and 10 females) aged 41-75 years with established stable exertional angina pectoris were studied in a double-blind fashion to confirm the efficacy of 80 mg propranolol administered three times daily and also to examine its effect on ST-segment changes in the electrocardiogram by ambulatory ST-segment monitoring and exercise testing using on-line computer analysis. During ambulatory monitoring, episodes of ST-segment depression in lead CM5 were significantly reduced from 6.5 +/- 0.7 during placebo to 3.4 +/- 0.6 during propranolol therapy (p less than 0.001). The total duration of ST-segment depression was also significantly reduced and the maximal depth of ST-segment depression improved from 2.6 +/- 0.2 mm during placebo to 1.7 +/- 0.2 mm during propranolol therapy (p less than 0.001). The mean +/- SEM exercise time of 5.5 +/- 0.2 minutes on placebo increased to 8.6 +/- 0.4 minutes on propranolol 240 mg daily (p less than 0.001). The 1 mm ST-segment depression time of 3.5 +/- 0.2 minutes on placebo in lead CM5 was prolonged to 6.2 +/- 0.3 minutes during propranolol therapy (p less than 0.001). Propranolol treatment significantly reduced the resting and maximal heart rates (p less than 0.001). The maximal ST-segment depression during exercise in lead CM5 was reduced from 2.3 +/- 0.1 mm on placebo to 1.9 +/- 0.1 mm with propranolol (p less than 0.01). Similarly, the rate-pressure product at peak exercise of 188 +/- 5 units on placebo was reduced to 144 +/- 3 units with propranolol (p less than 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)
 ...
PMID:Effect of propranolol on indices of intermittent myocardial ischemia, assessed by exercise testing and ambulatory ST-segment monitoring. 373 66

Changes in ST-T complex were studied using Holter electrocardiographic monitoring in 83 male patients with stable angina of effort. Episodes of transitory ST displacement were detected in 74.8% of patients. Of the recorded 886 ST displacement episodes, ST depression was seen in 35.9% of cases, with accompanying anginal pain in 88.4% of those. ST elevation was seen in 64.1% of cases, but anginal pain only accompanied a more than 2 mm elevation in 3.2% of those, while 96.8% of 1-2 mm elevations were asymptomatic. Total duration of ST depression was found to be an objective criterion for the assessment of the severity of stable angina of effort, amounting to less than 1% of the day in patients referred to functional class (FC) 1, 1-4% in FC 2, 5-10% in FC 3 and more than 10% in FC 4.
 ...
PMID:[Transient changes in the ST-T complex of patients with stable stenocardia of effort during 24-hour ECG monitoring]. 376 20

Nineteen patients with syndrome X (typical exertional angina, positive exercise test response [at least 0.1 mV of ST-segment depression], no evidence of coronary spasm and angiographically normal coronary arteries) underwent continuous 48-hour electrocardiographic (ECG) monitoring during unrestricted daily life. Fifty-eight ischemic episodes of at least 0.1 mV of ST-segment depression were observed in the same ECG leads that showed ST depression during stress testing: 28 (48%) were accompanied by anginal pain and 30 (52%) were asymptomatic. No significant differences were found between painful and silent ST-segment depression with regard to the number of episodes, their temporal distribution, magnitude, duration or heart rate (HR) at onset of ST-segment depression. In the minute preceding ischemic ST shifts, HR did not change in 33% of episodes or increased by less than 10 beats/min in 28%. HR at onset of ST depression was significantly lower during ambulatory ECG monitoring than during exercise testing (98 +/- 18 vs 117 +/- 18 beats/min, p less than 0.01). During ambulatory monitoring, 85 episodes of sinus tachycardia (exceeding by 10 to 80 beats/min the HR that triggered ischemia during exercise testing) occurred in the absence of angina or ST-segment shifts. The results of this study suggest that in patients with syndrome X, myocardial ischemia frequently develops during daily life; silent ischemia is an important component of this syndrome; and increased oxygen demand in the presence of impaired coronary vasodilatory capacity is not the only cause of myocardial ischemia. Active mechanisms that transiently reduce coronary flow may act and explain occurrence of angina at rest and with minimal exertion.
 ...
PMID:Transient myocardial ischemia during daily life in patients with syndrome X. 378 14

In order to assess the long-term efficacy of diltiazem for the treatment of angina pectoris, eight patients with chronic stable exertional angina who were previously entered into a 4-month randomized, double-blind placebo controlled study, were studied for an additional 12-months. The patients continued to take diltiazem, 360 mg/day, and underwent treadmill exercise testing after 10 and 16 months of therapy. A single-blind placebo week was introduced after 16 months and a treadmill test was performed at the end of this week. Diltiazem therapy continued to augment exercise duration until 0.1 mV of ECG ST depression at 10 and 16 months as compared to the final placebo period: 573 +/- 133 (SD) seconds at 10 months; 565 +/- 148 seconds at 16 months; vs 431 +/- 151 seconds at final placebo (both p less than 0.001). Also, the time to angina pectoris was prolonged on diltiazem by 181 seconds at 16 months (p less than 0.01) and the total duration of exercise was increased by 101 seconds (p less than 0.001) as compared to placebo. In addition, angina frequency decreased from 17 +/- 11 attacks/week on placebo to 0.6 +/- 0.6 attacks/week during diltiazem therapy at 16 months. Two of the eight patients noted mild pedal edema, but no other adverse effects were experienced. Thus diltiazem, 360 mg/day, can be an effective single agent for the long-term treatment of chronic stable angina pectoris.
 ...
PMID:Long-term efficacy of high-dose diltiazem for chronic stable angina pectoris: 16-month serial studies with placebo controls. 388 Sep 93

The clinical and hemodynamic effects of propranolol, propranolol-verapamil (P-V), propranolol-nifedipine (P-N) and propranolol-diltiazem (P-D) were studied in 19 patients with chronic exertional angina pectoris. A placebo-controlled, double-blind, randomized, crossover study design was used in which patients took each treatment for a 4-week period. The 3 combinations equally reduced the incidence of angina attacks and decreased ST-segment depression. Left ventricular hypokinesia during exercise was lessened and end-systolic volume during exercise decreased with all combinations. Because of a corresponding reduction of normokinetic segmental function, global ejection fraction during exercise remained unchanged. Heart size increased (p less than 0.05) and the PR interval lengthened (p less than 0.001) with P-V and P-D compared to P-N. The largest number of adverse clinical reactions occurred with P-V, whereas the fewest occurred with P-D. Almost all patients preferred combined therapy over propranolol and many favored 1 combination over the others. In summary, when therapy with combined beta- and calcium channel-blocking drugs is planned, P-D should be considered the combination of first choice because of its low incidence of adverse clinical effects. In the presence of possible or definite abnormalities of atrioventricular nodal conduction or decreased left ventricular function, P-N should be considered. Although P-V is associated with frequent adverse reactions, a trial may be warranted if the other combinations are unsuccessful.
 ...
PMID:Clinical and hemodynamic evaluation of propranolol in combination with verapamil, nifedipine and diltiazem in exertional angina pectoris: a placebo-controlled, double-blind, randomized, crossover study. 388 39

Eighteen patients with exertional angina were treated with diltiazem (360 mg/day). Serial exercise testing was performed and the results were compared to evaluations when patients were receiving placebo at the initiation and termination of the study. Serial exercise tests indicated significant improvement in duration of exercise (+18%, p less than 0.001), time to 1 mm ST depression (+32%, p less than 0.005), and time to angina (+46%, p less than 0.001) when patients were receiving diltiazem. During diltiazem treatment, there was a significant reduction in myocardial oxygen demand as indicated by the change in submaximal pressure rate product. This may contribute to the beneficial effect of diltiazem in patients with exertional angina. The reduction in pressure rate product was due primarily to a change in heart rate. This study provides evidence that diltiazem is an effective long-term monotherapy for angina; no evidence of drug tachyphylaxis was apparent after a total of 16 months treatment with diltiazem.
 ...
PMID:Long-term monotherapy of angina pectoris with diltiazem. 389 16

The anti-anginal effects of KB-944 (Fostedil), a new calcium ion antagonist with a half life of approximately 23-28 hr, were evaluated in 20 patients with exertional angina pectoris in a placebo-controlled single-blind dose titration trial. Ambulatory monitoring and multistage treadmill exercise with computer-assisted electrocardiographic analysis was performed after 2 weeks of placebo therapy and after two 2-weekly periods of KB-944 therapy. The mean (+/- SEM) exercise time to the development of angina on treadmill walking increased from 6.9 +/- 0.4 min on placebo to 9.4 +/- 0.5 min on KB-944 100 mg/day (P less than 0.001) and 9.7 +/- 0.8 min on KB-944 200 mg/day (P less than 0.001 vs placebo and not significant vs KB-944 100 mg/day). The time to the development of 1 mm ST-segment depression of 5.3 +/- 0.4 min on placebo increased to 6.5 +/- 0.5 and 6.6 +/- 0.5 min on KB-944 100 and 200 mg/day, respectively (P less than 0.01 vs placebo). The heart rate at rest of 77 +/- 3 beats/min on placebo was reduced to 68 +/- 3 beats/min on KB-944 100 mg/day (P less than 0.001) and 71 +/- 2 beats/min on KB-944 200 mg/day (P less than 0.01). The maximal heart rate and the rate-pressure product were not altered by KB-944 therapy. One patient developed unstable angina during the treatment phase of KB-944 200 mg/day and was withdrawn. Five patients complained of dyspepsia and one of headache and lethargy during KB-944 200 mg/day. One patient developed ventricular tachycardia during treadmill testing while on KB-944 200 mg/day. The 24-hr ambulatory monitoring data confirmed the findings of exercise testing. KB-944 (Fostedil) in a dose of 100 mg once daily was well tolerated as compared to KB-944 200 mg once daily and both the doses were equally effective. The drug merits further evaluation for the treatment of exertional angina pectoris.
 ...
PMID:Ambulatory monitoring and exercise testing in the evaluation of a new long-acting calcium ion antagonist KB-944 (Fostedil) for the treatment of exertional angina pectoris. 390 75

The haemodynamic and electrocardiographic effects of amiodarone, diltiazem, and glyceryl trinitrate (nitroglycerin) were compared in an open study of 18 patients with stable exertional angina using a graded treadmill exercise test. Amiodarone and diltiazem exerted similar antianginal effectiveness as assessed by increases in exercise performance and duration of exercise, as well as decreases in ST-segment depression. The antianginal efficacy of glyceryl trinitrate was somewhat lower than that of the other 2 agents. All the drugs were well tolerated.
 ...
PMID:An open comparison of amiodarone with diltiazem and glyceryl trinitrate in patients with stable exertional angina. 392 33

Nitroglycerin 0.5 mg sublingually was tested in two exercise protocols in order to determine the time of onset of the anti-anginal action. When patients stopped exertion after nitroglycerin administered at the time of moderate chest pain and one minute before stopping exercise, no anti-anginal or anti-ischaemic effect was seen compared with a placebo-medicated test given double-blindly. When the patients continued exertion after nitroglycerin administered at the onset of chest pain, a significant decrease in chest pain intensity and an improvement in ST-segment depression was seen. It is concluded that administration of a quick-acting anti-anginal drug at the onset of chest pain during continued bicycle exercise provides a suitable test model to determine the time of onset of action in exertional angina pectoris.
 ...
PMID:The time of onset of action of sublingual nitroglycerin in exercise-induced angina pectoris. A methodological study. 393 Feb 48

The high count sensitivity of the non-imaging nuclear probe affords the possibility of measuring left ventricular ejection fraction continuously during short term interventions. The nuclear probe was used to examine the pattern of change of left ventricular function during dynamic exercise and its temporal relation to ST segment depression in 12 patients with stable exertional angina. After in vivo blood pool labelling with technetium-99m the left ventricular time-activity waveform was detected by the nuclear probe and was continuously recorded on a strip chart. The 15 beat mean ejection fraction and the ST segment level 80 ms after the J point were measured at rest and every 30 seconds during maximal ergometric exercise and during recovery. The mean ejection fraction was 54.3% (range 46-64%) at rest and fell during exercise in all subjects by a mean of 16.8% (range 6-25%). In contrast, in a control group of 16 healthy male volunteers the mean ejection fraction was 55.9% (range 47-64%) at rest and increased in all by a mean of 10.2% (range 3-19%) during exercise. The difference of ejection fraction response to exercise between the patients and controls was due to pronounced increases in relative end diastolic and especially end systolic volumes in the patients. Relative stroke volume differed between patients and controls only at peak exercise. ST segment depression greater than 1 mm developed in 11 of the 12 patients. A decrease of greater than 5% in ejection fraction occurred within 1 minute of starting exercise in nine of the 12, and in 11 patients it preceded the beginning of ST depression. In most of this selected group of patients the ejection fraction had fallen during exercise before the appearance of ischaemic electrocardiographic changes.
 ...
PMID:Changes in left ventricular function during exercise and their relation to ST segment changes in patients with angina. 394 49


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>